AIP - Arteris, Inc. Stock Price, Fair Value and News

7.92USD-0.22 (-2.70%)Delayed as of 17 May 2024, 11:00 am ET

Market Summary

USD7.92-0.22

Delayedas of 17 May 2024, 11:00 am

-2.70%

AIP Stock Price

View Fullscreen

AIP RSI Chart

AIP Valuation

Market Cap

313.2M

Price/Earnings (Trailing)

-8.41

Price/Sales (Trailing)

5.86

EV/EBITDA

-10.01

Price/Free Cashflow

-37.1

AIP Price/Sales (Trailing)

AIP Profitability

EBT Margin

-60.21%

Return on Equity

-390.34%

Return on Assets

-36.76%

Free Cashflow Yield

-2.7%

AIP Fundamentals

AIP Revenue

Revenue (TTM)

53.5M

Rev. Growth (Yr)

-1.57%

Rev. Growth (Qtr)

3.54%

AIP Earnings

Earnings (TTM)

-37.3M

Earnings Growth (Yr)

-4.36%

Earnings Growth (Qtr)

10.8%

Breaking Down AIP Revenue

52 Week Range

5.138.12

(Low)(High)

Last 7 days

-3.7%

Last 30 days

15.7%

Last 90 days

9.3%

Trailing 12 Months

63.5%

How does AIP drawdown profile look like?

AIP Financial Health

Current Ratio

1.24

AIP Investor Care

Shares Dilution (1Y)

8.79%

Diluted EPS (TTM)

-1.02

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	53.5M	0	0	0
2023	51.8M	51.7M	52.4M	53.7M
2022	43.0M	47.0M	50.6M	50.4M
2021	33.3M	34.8M	36.4M	37.9M
2020	0	0	0	31.8M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Arteris, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
May 01, 2024	alpern paul l	acquired	6,350	0.564444	11,250	vp and general counsel
May 01, 2024	alpern paul l	sold	-71,853	6.38699	-11,250	vp and general counsel
Apr 11, 2024	hawkins nicholas b.	sold	-72,161	7.2161	-10,000	vp and chief financial officer
Apr 05, 2024	viana antonio j	acquired	-	-	2,781	-
Apr 04, 2024	hawkins nicholas b.	sold	-16,323	7.2809	-2,242	vp and chief financial officer
Apr 03, 2024	moll laurent r	sold	-4,166	7.1721	-581	chief operating officer
Apr 03, 2024	alpern paul l	sold	-23,625	7.1766	-3,292	vp and general counsel
Apr 02, 2024	alpern paul l	sold	-17,601	7.0267	-2,505	vp and general counsel
Apr 02, 2024	janac k charles	sold	-71,000	7.02763	-10,103	president and ceo
Apr 02, 2024	moll laurent r	sold	-29,448	7.0267	-4,191	chief operating officer

Which funds bought or sold AIP recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 15, 2024	Mariner, LLC	reduced	-0.54	39,932	209,052	-%
May 15, 2024	EVENTIDE ASSET MANAGEMENT, LLC	unchanged	-	570,603	2,920,850	0.05%
May 15, 2024	TWO SIGMA ADVISERS, LP	added	38.4	147,995	353,556	-%
May 15, 2024	Brevan Howard Capital Management LP	new	-	170,029	170,029	-%
May 15, 2024	Tower Research Capital LLC (TRC)	added	8,078	46,830	47,295	-%
May 15, 2024	WESTERLY CAPITAL MANAGEMENT, LLC	added	75.00	1,245,600	2,305,800	0.87%
May 15, 2024	BOOTHBAY FUND MANAGEMENT, LLC	sold off	-100	-74,391	-	-%
May 15, 2024	Cubist Systematic Strategies, LLC	new	-	269,164	269,164	-%
May 15, 2024	Man Group plc	added	37.72	278,967	670,988	-%
May 15, 2024	SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC	sold off	-100	-4,257,540	-	-%

Are Funds Buying or Selling AIP?

Are funds buying AIP calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own AIP

No. of Funds

Unveiling Arteris, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Jan 24, 2024	ventech capital f	5.6%	2,054,782	SC 13G/A
Jan 24, 2024	bayview legacy, llc	28.0%	10,307,691	SC 13G/A
Feb 08, 2023	ventech capital f	9.3%	3,111,046	SC 13G/A
Feb 08, 2023	bayview legacy, llc	30.9%	10,323,891	SC 13G/A
Feb 10, 2022	bayview legacy, llc	33.1%	10,335,891	SC 13G
Feb 10, 2022	ventech capital f	10.0%	3,127,907	SC 13G

Recent SEC filings of Arteris, Inc.

View All Filings

Date Filed	Form Type	Document
May 14, 2024	4	Insider Trading
May 03, 2024	4	Insider Trading
May 02, 2024	10-Q	Quarterly Report
May 02, 2024	8-K	Current Report
Apr 23, 2024	ARS	ARS
Apr 23, 2024	DEF 14A	DEF 14A
Apr 23, 2024	DEFA14A	DEFA14A
Apr 15, 2024	4	Insider Trading
Apr 09, 2024	4	Insider Trading
Apr 04, 2024	144	Notice of Insider Sale Intent

Peers (Alternatives to Arteris, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
NVDA	2.4T	60.9B	7.96%	212.71%	79.28	38.73	125.85%	581.31%
AMD	262.8B	22.8B	-0.52%	56.73%	235.51	11.53	-1.16%	182.53%
AMAT	177.9B	26.5B	2.17%	70.26%	24.85	6.72	0.88%	10.98%
INTC	136.4B	55.2B	-11.64%	10.98%	33.55	2.47	-2.09%	242.32%
ADI	106.2B	11.6B	11.97%	13.92%	37.71	9.18	-8.03%	-17.90%
MID-CAP
AMKR	8.1B	6.4B	5.51%	44.56%	21.73	1.27	-8.17%	-41.71%
CRUS	6.1B	1.8B	30.79%	41.97%	34.38	3.38	-11.16%	-46.12%
ACLS	3.7B	1.1B	8.91%	-17.49%	14.77	3.27	16.34%	32.25%
DIOD	3.3B	1.5B	5.84%	-22.08%	19.64	2.23	-24.64%	-48.42%
AMBA	2.0B	226.5M	7.62%	-31.52%	-11.58	8.66	-32.92%	-159.10%
SMALL-CAP
ACMR	1.5B	635.7M	-15.01%	146.08%	17.15	2.36	51.02%	67.91%
AOSL	782.1M	657.5M	27.54%	5.26%	-82.74	1.19	-9.15%	-119.91%
AEHR	333.7M	71.9M	-0.35%	-61.45%	21.66	4.64	14.14%	8.17%
ATOM	122.1M	550.0K	-25.00%	-48.23%	-6.23	221.94	43.98%	-6.63%
ASYS	74.9M	108.8M	10.33%	-39.46%	-3.49	0.69	1.54%	-244.16%

Arteris, Inc. News

Latest updates

Arteris, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)															(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3
Revenue	3.5%	12,947,000	12,504,000	13,274,000	14,734,000	13,154,000	11,203,000	12,598,000	14,822,000	11,755,000	11,434,000	8,959,000	10,813,000	6,658,000	6,543,500	6,429,000
Gross Profit	3.8%	11,479,000	11,056,000	11,994,000	13,509,000	12,030,000	10,118,000	11,670,000	13,533,000	10,776,000	10,321,000	8,076,000	9,946,000	5,790,000	-	6,202,000
Operating Expenses	1.5%	20,613,000	20,305,000	20,447,000	22,192,000	20,787,000	19,178,000	19,424,000	18,959,000	17,392,000	17,601,000	12,593,000	13,467,000	12,237,000	-	8,821,000
S&GA Expenses	8.5%	5,456,000	5,029,000	5,024,000	5,601,000	5,005,000	4,631,000	4,411,000	4,456,000	3,921,000	3,755,000	3,242,000	2,281,000	2,448,000	-	2,240,000
R&D Expenses	1.6%	10,835,000	10,663,000	10,997,000	12,087,000	11,381,000	10,318,000	11,022,000	10,371,000	9,456,000	10,240,000	7,609,000	6,425,000	6,538,000	-	4,011,000
EBITDA Margin	-0.8%	-0.54	-0.53	-0.54	-0.56	-0.51	-0.50	-0.49	-0.47	-0.49	-0.55	-0.03	-0.04	-0.04	-0.04	-
Interest Expenses	1.3%	76,000	75,000	77,000	27,000	32,000	29,000	22,000	18,000	20,000	-	-	-	-	-	-
Income Taxes	-69.1%	370,000	1,198,000	-398,000	556,000	300,000	-1,116,500	248,000	351,000	100,000	412,000	268,000	188,000	200,000	-	1,199,000
Earnings Before Taxes	1.6%	-8,274,000	-8,407,000	-7,632,000	-7,875,000	-7,881,000	-8,070,000	-7,436,000	-5,317,000	-6,697,000	-7,362,000	-4,700,000	-3,721,000	-6,561,000	-	-2,645,000
EBT Margin	-1.6%	-0.60	-0.59	-0.60	-0.60	-0.55	-0.55	-0.53	-0.51	-0.52	-0.59	-0.06	-0.06	-0.07	-0.07	-
Net Income	10.8%	-9,403,000	-10,541,000	-8,153,000	-9,165,000	-9,010,000	-7,215,000	-7,684,000	-5,668,000	-6,820,000	-7,790,000	-4,968,000	-3,909,000	-6,717,000	-	-3,844,000
Net Income Margin	-1.5%	-0.70	-0.69	-0.64	-0.64	-0.57	-0.54	-0.55	-0.54	-0.55	-0.62	-0.09	-0.09	-0.10	-0.10	-
Free Cashflow	108.2%	281,000	-3,407,000	-3,146,000	-2,170,000	-8,509,000	-787,000	-5,663,000	85,000	-1,453,000	2,872,000	-2,629,000	-2,342,000	477,000	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet												(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2020Q4
Assets	-1.4%	101	103	102	107	107	116	119	121	112	120	41.00	43.00
Current Assets	5.8%	62.00	58.00	62.00	70.00	76.00	81.00	91.00	95.00	99.00	107	24.00	29.00
Cash Equivalents	93.5%	27.00	14.00	19.00	26.00	29.00	37.00	68.00	81.00	82.00	86.00	11.00	12.00
Net PPE	-8.7%	5.00	6.00	5.00	5.00	3.00	4.00	4.00	3.00	2.00	2.00	2.00	2.00
Goodwill	0.5%	4.00	4.00	4.00	4.00	4.00	4.00	3.00	3.00	3.00	3.00	3.00	3.00
Liabilities	4.7%	92.00	88.00	80.00	80.00	76.00	78.00	78.00	75.00	65.00	68.00	56.00	49.00
Current Liabilities	7.4%	50.00	46.00	45.00	44.00	41.00	44.00	44.00	43.00	40.00	42.00	37.00	28.00
Shareholder's Equity	-36.8%	10.00	15.00	22.00	27.00	32.00	38.00	40.00	46.00	48.00	53.00	-	-
Retained Earnings	-9.1%	-112	-103	-92.71	-84.55	-75.39	-66.38	-59.16	-51.48	-45.81	-38.99	-31.20	-15.61
Additional Paid-In Capital	3.3%	122	118	115	111	107	104	100	97.00	94.00	92.00	11.00	4.00
Shares Outstanding	2.1%	38.00	38.00	37.00	36.00	35.00	35.00	33.00	32.00	32.00	32.00	21.00	-
Float	-	-	-	-	163	-	-	-	144	-	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)															(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3
Cashflow From Operations	116.0%	477	-2,979	-2,806	-1,555	-8,389	-391	-5,213	198	-1,361	3,192	-2,500	-2,022	516	-	-
Share Based Compensation	2.9%	3,657	3,554	3,714	4,282	2,985	2,610	3,389	3,384	2,309	4,366	433	378	333	-	-
Cashflow From Investing	970.0%	11,902	-1,368	-3,694	-50.00	421	-30,148	-6,608	-442	-283	-871	-129	-320	-39.00	-	-
Cashflow From Financing	107.5%	44.00	-584	-1,207	-178	-950	-238	-1,280	-691	-1,945	72,263	-939	5,130	-200	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

AIP Income Statement

2024-03-31

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Statement of Comprehensive Income [Abstract]
Net loss	$ (9,403)	$ (9,010)
Other comprehensive loss:
Unrealized (losses) gains on available-for-sale securities, net of tax	(66)	11
Comprehensive loss	$ (9,469)	$ (8,999)

AIP Balance Sheet

2024-03-31

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 26,119	$ 13,696
Short-term investments (Note 5)	18,695	27,477
Accounts receivable, net of allowance of $93 as of both March 31, 2024 and December 31, 2023	12,265	12,003
Prepaid expenses and other current assets	4,718	5,254
Total current assets	61,797	58,430
Property and equipment, net	5,244	5,745
Long-term investments (Note 5)	8,602	11,802
Equity method investment	7,741	8,500
Operating lease right-of-use assets	4,060	4,289
Intangibles, net	3,662	3,858
Goodwill	4,178	4,178
Other assets	6,070	5,999
TOTAL ASSETS	101,354	102,801
Current liabilities:
Accounts payable	754	183
Accrued expenses and other current liabilities	12,659	11,831
Operating lease liabilities, current	858	781
Deferred revenue, current	33,558	31,537
Vendor financing arrangements, current	1,987	2,070
Total current liabilities	49,816	46,402
Deferred revenue, noncurrent	26,559	25,172
Operating lease liabilities, noncurrent	3,333	3,610
Vendor financing arrangements, noncurrent	1,094	1,292
Deferred income, noncurrent	8,520	8,810
Other liabilities	2,486	2,412
Total liabilities	91,808	87,698
Commitments and contingencies (Note 10)
Stockholders' equity:
Preferred stock, par value of $0.001 - 10,000,000 shares authorized as of both March 31, 2024 and December 31, 2023; no shares issued and outstanding as of both March 31, 2024 and December 31, 2023	0	0
Common stock, par value of $0.001 - 300,000,000 shares authorized as of both March 31, 2024 and December 31, 2023; 38,291,425 and 37,518,583 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	38	37
Additional paid-in capital	122,104	118,193
Accumulated other comprehensive income	54	120
Accumulated deficit	(112,650)	(103,247)
Total stockholders' equity	9,546	15,103
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 101,354	$ 102,801

About Arteris, Inc.

Arteris, Inc. provides semiconductor interconnect intellectual property (IP) and IP deployment solutions in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in System-on-Chip (Soc) designs and Network-on-Chip (NoC) interconnect IP. Its products include FlexNoC and FlexWay silicon-proven interconnect IP products; Ncore, a silicon-proven and cache coherent interconnect IP product that provides scalable, configurable, and area efficient characteristics; and CodaCache, a last-level cache semiconductor IP product. The company also offers IP deployment products comprising Magillem Connectivity that shortens and streamlines the SoC integration process; Magillem Registers and CSRCompiler that addresses hardware-software integration challenges for SoCs; and Harmony Trace that provides an enterprise-level server-based application with a web-based user interface. The company serves semiconductor manufacturers, original equipment manufacturers, hyperscale system houses, semiconductor design houses, and other producers of electronic systems. Arteris, Inc. was founded in 2003 and is headquartered in Campbell, California.

CEO	Mr. Karel Charles Janac
WEBSITE	arteris.com
INDUSTRY	Semiconductors
EMPLOYEES	248

Arteris, Inc. Frequently Asked Questions

What is the ticker symbol for Arteris, Inc.? What does AIP stand for in stocks?

AIP is the stock ticker symbol of Arteris, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Arteris, Inc. (AIP)?

As of Thu May 16 2024, market cap of Arteris, Inc. is 313.22 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AIP stock?

You can check AIP's fair value in chart for subscribers.

What is the fair value of AIP stock?

You can check AIP's fair value in chart for subscribers. The fair value of Arteris, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Arteris, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for AIP so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Arteris, Inc. a good stock to buy?

The fair value guage provides a quick view whether AIP is over valued or under valued. Whether Arteris, Inc. is cheap or expensive depends on the assumptions which impact Arteris, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AIP.

What is Arteris, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu May 16 2024, AIP's PE ratio (Price to Earnings) is -8.41 and Price to Sales (PS) ratio is 5.86. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AIP PE ratio will change depending on the future growth rate expectations of investors.